Skip to main content

Cytokine Involvement in Tumor Development and Tumor Suppression

  • Conference paper
  • 91 Accesses

Abstract

Cytokines constitute a class of soluble small proteins which previously have been designated monokines, lymphokines, or interleukins. They represent the intercellular signaling system for hematopoiesis and immune reactions. During the last 10 years 20 or more cytokine genes have been cloned. This allowed their careful characterization in a number of different regards. Cytokines regulate hematopoietic cell differentiation and proliferation and determine intensity and duration of immune reactions. The common characteristic feature of cytokines is that they are pleiotropic, that different cytokines may have redundant activities, and that they form a complex, poorly understood network in vivo. Depending on the experimental situation and on the cytokine which is analyzed, cytokines may have both deleterious and beneficial consequences for tumor cell growth.

This work was supported by the Deutsche Forschungsgemeinschaft (B1 288/1-1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 318: 745–747

    Article  Google Scholar 

  2. Lang RA, Burgess AW (1990) Autocrine growth factors and tumourigenic transformation. Immunol Today 11: 244–249

    Article  PubMed  CAS  Google Scholar 

  3. Jücker M, Abts H, Li W, Schindler R, Merz H, Günther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC, Krueger GRF, Diehl V, Blankenstein T, Tesch H (1991) Expression of interleukin 6 and interleukin 6 receptor in Hodgkin’s disease. Blood 77: 2413–2418

    PubMed  Google Scholar 

  4. Schaadt M, von Kalle C, Tesch H, Burrichter H, Diehl V (1988) Immunologic, functional and molecular genetic properties of Hodgkin-derived cell lines. Cancer Rev 10: 108–122

    Google Scholar 

  5. Hutchins D, Cohen BB, Steel CM (1990) Production and regulation of interleukin 6 in human B lymphoid cells. Eur J Immunol 20: 961–968

    Article  PubMed  CAS  Google Scholar 

  6. Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Kishimoto T (1987) Structure and expression of human B cell stimulatory factor 2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945

    PubMed  CAS  Google Scholar 

  7. Qin Z, Schuller I, Richter G, Diamantstein T, Blankenstein T (1991) The interleukin 6 locus seems to be a preferred target site for retrotransposon integration. Immunogenetics 33: 260–267

    Article  PubMed  CAS  Google Scholar 

  8. Blankenstein T, Qin Z, Li W, Diamantstein T (1990) DNA rearrangement and constitutive expression of the interleukin 6 gene in a mouse plasmacytoma. J Exp Med 171: 965–970

    Article  PubMed  CAS  Google Scholar 

  9. Blankenstein T, Qin Z, Überla K, Müller W, Rosen H, Volk HD, Diamantstein T (1991) Tumor suppression after tumor cell targeted tumor necrosis factor a gene transfer. J Exp Med 173: 1047–1052

    Article  PubMed  CAS  Google Scholar 

  10. Blankenstein T, Li W, Überla K, Qin Z, Tominaga A, Takatsu K, Yamaguchi N, Diamantstein T (1990) Retroviral interleukin 5 gene transfer into interleukin 5 dependent growing cell lines results in autocrine growth and tumorigenicity. Eur J Immunol 20: 2699–2705

    Article  PubMed  CAS  Google Scholar 

  11. Blankenstein T, Li W, Müller W, Diamantstein T (1990) Retroviral interleukin 4 gene transfer into an interleukin 4 dependent cell line results in autocrine growth but not in tumorigenicity. Eur J Immunol 20: 935–938

    Article  PubMed  CAS  Google Scholar 

  12. Li W, Diamantstein T, Blankenstein T (1990) Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. Mol Immunol 27: 1331–1337

    Article  PubMed  CAS  Google Scholar 

  13. Blankenstein T, Qin Z, Überla K, Volk HD, Diamantstein T (1990) Tumor cell targeted cytokine ( TNFa) gene therapy for cancer. Immunol Today 11: 431

    Google Scholar 

  14. Blankenstein T, Rowley DA, Schreiber H (1991) Cytokines and cancer; experimental systems. Curr Opin Immunol 3: 694–698

    Article  PubMed  CAS  Google Scholar 

  15. Überla K, Li W, Qin Z, Richter G, Raabe T, Diamantstein T, Blankenstein T (1991) The rat interleukin 5 gene: characterization and expression by retroviral gene transfer and polymerase chain reaction. Cytokine 3: 72–81

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Dorsch, M., Diamantstein, T., Blankenstein, T. (1992). Cytokine Involvement in Tumor Development and Tumor Suppression. In: Freund, M., Link, H., Schmidt, R.E., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48715-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48715-6_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55242-0

  • Online ISBN: 978-3-642-48715-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics